Rare COVID-19 vaccine blood clots explained

Rare COVID-19 vaccine blood clots explained

Up next

What’s Canada’s new national security plan?

For the first time in 22 years, Canada has released a new national security strategy. The 13-page document lays out the government’s goals and priorities for, as they put it, a “stronger Canada”. It covers everything from military spending and protecting the Arctic to bolstering ...  Show more

Carney’s big federal budget bets

The federal budget was unveiled Thursday afternoon, and it lays out some of the big bets the Carney government plans on making in the years ahead. A $36-billion tax break to kickstart an “investment supercycle”. A number of affordability measures. A plan to end homelessness withi ...  Show more

Recommended Episodes

Halted: Johnson & Johnson & the Vaccination Timeline
Squawk Pod

After 6 people in nearly 7 million Johnson & Johnson vaccine recipients developed a rare type of blood clot, the FDA and CDC have recommended a pause on administering that vaccine in the United States. CNBC’s Meg Tirrell digests the news and what it means for the rest of the J&J ...  Show more

Coronavirus: How Scary Are the Variants?
Science Vs

UPDATE 4/13/21: Since this episode published, there has been some evidence linking the Johnson & Johnson coronavirus vaccine to rare blood clots. As of April 13, there were six cases in the U.S. out of more than 6.8 million doses, and one person had died. The CDC and FDA have rec ...  Show more

Are all viral vector vaccines a problem?
What's That Rash?

American health regulators have paused the use of the Johnson & Johnson coronavirus vaccine, following reports of rare blood clotting in six recipients. Like the AstraZeneca vaccine, Johnson & Johnson is what's known as a viral vector vaccine - where another virus is used like a ...  Show more